Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04421040 · ClinicalTrials.gov registry record · NA
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04421040: Completed NA study, sponsored by Mayo Clinic.
NCT04421040 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04421040, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Researchers are gathering information to see if using an FDA approved implantable device can help with monitoring of your heart arrhythmias.
Interventions
- DEVICE Biotronik Biomonitor 3 implant of device
- DEVICE Biotronik Biomonitor 3 explant of device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-10-07 |
| Est. Completion | 2023-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04421040
The ClinicalTrials.gov registry entry for NCT04421040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biotronik Biomonitor 3 implant of device is the first listed.
NCT04421040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04421040 about?
NCT04421040 is a clinical study titled "Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors". Researchers are gathering information to see if using an FDA approved implantable device can help with monitoring of your heart arrhythmias.
What is the current status of trial NCT04421040?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-10-07. Estimated completion is 2023-03-22.
What interventions are being tested in trial NCT04421040?
The interventions under investigation include: Biotronik Biomonitor 3 implant of device (DEVICE), Biotronik Biomonitor 3 explant of device (DEVICE).
Who is sponsoring clinical trial NCT04421040?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.